![]() |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]()
![]()
![]()
Key reference
DOI no: 10.1074/jbc.M609526200 J Biol Chem 282:4172-4184 (2007) PubMed id: 17148455 ![]()
The NMR solution structure of the relaxin (RXFP1) receptor lipoprotein receptor class A module and identification of key residues in the N-terminal region of the module that mediate receptor activation. E.J.Hopkins, S.Layfield, T.Ferraro, R.A.Bathgate, P.R.Gooley. ![]()
ABSTRACT ![]()
![]()
The receptors for the peptide hormones relaxin and insulin-like peptide 3 (INSL3) are the leucine-rich repeat-containing G-protein-coupled receptors LGR7 and LGR8 recently renamed as the relaxin family peptide (RXFP) receptors, RXFP1 and RXFP2, respectively. These receptors differ from other LGRs by the addition of an N-terminal low density lipoprotein receptor class A (LDLa) module and are the only human G-protein-coupled receptors to contain such a domain. Recently it was shown that the LDLa module of the RXFP1 and RXFP2 receptors is essential for ligand-stimulated cAMP signaling. The mechanism by which the LDLa module modulates receptor signaling is unknown; however, it represents a unique paradigm in understanding G-protein-coupled receptor signaling. Here we present the structure of the RXFP1 receptor LDLa module determined by solution NMR spectroscopy. The structure is similar to other LDLa modules but shows small differences in side chain orientations and inter-residue packing. Interchange of the module with the second ligand binding domain of the LDL receptor, LB2, results in a receptor that binds relaxin with full affinity but is unable to signal. Furthermore, we demonstrate via structural studies on mutated LDLa modules and functional studies on mutated full-length receptors that a hydrophobic surface within the N-terminal region of the module is essential for activation of RXFP1 receptor signal in response to relaxin stimulation. This study has highlighted the necessity to understand the structural effects of single amino acid mutations on the LDLa module to fully interpret the effects of these mutations on receptor activity.
![]()
![]()
![]()
Selected figure(s) ![]()
![]()
The above figures are reprinted by permission from the ASBMB: J Biol Chem (2007, 282, 4172-4184) copyright 2007. Figures were selected by an automated process. ![]()
![]()
Literature references that cite this PDB file's key reference
PubMed id Reference
![]()
19935741 X.J.Du, R.A.Bathgate, C.S.Samuel, A.M.Dart, and R.J.Summers (2010).
Cardiovascular effects of relaxin: from basic science to clinical therapy.Nat Rev Cardiol, 7, 48-58. 19377077 A.J.Ramsay, J.D.Hooper, A.R.Folgueras, G.Velasco, and C.López-Otín (2009).
Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis.Haematologica, 94, 840-849.
![]()
19416161 B.J.Hartley, D.J.Scott, G.E.Callander, T.N.Wilkinson, D.E.Ganella, C.K.Kong, S.Layfield, T.Ferraro, E.J.Petrie, and R.A.Bathgate (2009).
Resolving the unconventional mechanisms underlying RXFP1 and RXFP2 receptor function.Ann N Y Acad Sci, 1160, 67-73.
![]()
19416150 G.W.Tregear, R.A.Bathgate, M.A.Hossain, F.Lin, S.Zhang, F.Shabanpoor, D.J.Scott, S.Ma, A.L.Gundlach, C.S.Samuel, and J.D.Wade (2009).
Structure and activity in the relaxin family of peptides.Ann N Y Acad Sci, 1160, 5. The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.